New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline: Basel Saturday, May 17, 2025, 11:00 Hrs [IST] Novartis will present data from ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

Incyte INCY announced that the FDA has approved its new drug, Zynyz (retifanlimab-dlwr), a PD-1 inhibitor, for treating a new ...

These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...

GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

Concerns are being raised over plans to build hundreds of new houses and flats on land in Horsham that is feared could be ...

Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive ...

Greek use of interoperable digital tools and secure data platforms such as the EHDS could boost early detection and ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

THE Court of Tax Appeals (CTA) has granted a P31.75 million tax refund claim filed by a local importer of maintenance medicines for erroneously paid taxes in 2020. In a 19-page decision of the CTA’s ...

"We are very pleased to expand our IgA nephropathy campaign with new resources to help patients better understand this rare kidney disease,” said LaVarne A. Burton, AKF President and CEO. "With ...